Mode
Text Size
Log in / Sign up
N/A N=10 Treatment

Researching Emotions And Cardiac Health (REACH): Phase II

Congestive Heart Failure · Emotions · Patient Compliance

Enrolled (actual)
10
Serious AEs
20.0%
Results posted
Sep 2018
Primary outcome: Primary: Feasibility of the PP-based Health Behavior Intervention — 7.8 Exercises Completed

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
PP-based health behavior intervention (Behavioral)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Massachusetts General Hospital
Primary completion
Jul 2017

Outcome Measures

OutcomeResultp-value
PRIMARY
Feasibility of the PP-based Health Behavior Intervention
7.8
SECONDARY
Changes in PANAS Scores
2.44
SECONDARY
Changes in LOT-R Scores
1.56
SECONDARY
Changes in HADS-Anxiety Subscale Scores
2.0
SECONDARY
Change in HADS-Depression Subscale Scores
.11
SECONDARY
Changes in KCCQ Scores
5.56; 6.60
SECONDARY
Changes in SF-12 Scores
2.44; 2.17
SECONDARY
Changes in MOS SAS Scores
2.78
SECONDARY
Changes in Daily Sodium Intake (as Measured With the SSQ)
16.31
SECONDARY
Self-Reported Medication Adherence (SRMA)
.44
SECONDARY
Change in Physical Activity
706
SECONDARY
Change in Moderate to Vigorous Physical Activity (Actigraph)
.15
SECONDARY
Feasibility of Actigraph
9; 8
SECONDARY
Acceptability of the Exercises: Utility Score
7.8
SECONDARY
Acceptability of the Exercises: Ease Score
7.5
SECONDARY
Immediate Impact of the Exercises: Optimism Rating
8.2; 8.4
SECONDARY
Immediate Impact of the Exercises: Positive Affect Rating
7.8; 8.6

Summary

The focus of this study is to examine the feasibility, acceptability, and preliminary impact of our customized positive psychology (PP)-based health behavior intervention in a group of patients with mild to moderate heart failure (HF).

Eligibility Criteria

Inclusion Criteria

  • Adult patients with NYHA class I, II, or III HF admitted to an MGH inpatient unit or outpatients at the MGH Heart Center. Patients with NYHA class IV HF have ongoing HF symptoms at rest, making it difficult for them to increase physical activity and other health behaviors; therefore, they will not be included. HF diagnosis will be confirmed via chart review and with the patient's treatment team as needed.
  • Suboptimal adherence to health behaviors. This will be defined as a total score of ≤15 on three Medical Outcomes Study Specific Adherence Scale (MOS SAS) items regarding diet/exercise/medications. The MOS SAS has been used in multiple prior studies assessing adherence in cardiac patients, including our own studies in this population. This threshold score on the MOS SAS will ensure that all participants will have the potential to improve their health behaviors.

Exclusion Criteria

  • Cognitive deficits impeding a participant's ability to provide informed consent or participate, assessed via a 6-item cognitive test that is sensitive and specific for screening for cognitive impairment in research participants.
  • Medical conditions precluding interviews or likely to lead to death within 6 months.
  • Inability to speak English, inability to read or write, inability to walk, or lack of a telephone.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02938052). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search